Simplifying Global Compliance
New International Deal Lowers Price of Generic HIV Regimen to $75 Per Year
A new pricing agreement will allow a leading HIV regimen to be rolled out in more than 90 low- to middle-income countries, at an average cost of $75 per patient, per year.
To View This Article:
Subscribe To Generic Line
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing